top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, FASTTRACK CLINICAL RESEARCH, Gerasimos Filippatos, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan ...

Date : 14/07/2016
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 336949 bytes
Ehjournal

Abstract Mineralocorticoid receptor antagonists (MRAs) improve survival and reduce morbidity in patients with heart failure, reduced ejection fraction (HFREF), and mild-to-severe symptoms, and in ...

European Heart Journal, Zannad, Faiez, Gattis Stough, Wendy, Rossignol, Patrick, Bauersachs, Johann, McMurray, John J.V., Swedberg, Karl, Struthers, Allan D., Voors, Adriaan A., Ruilope, Luis M., ...

Date : 01/11/2012 Item size : 605295 bytes
Ehjournal

Abstract Aims To evaluate oral doses of the non-steroidal mineralocorticoid receptor antagonist finerenone given for 90 days in patients with worsening heart failure and reduced ejection fraction and ...

European Heart Journal, Filippatos, Gerasimos, Anker, Stefan D., Böhm, Michael, Gheorghiade, Mihai, Køber, Lars, Krum, Henry, Maggioni, Aldo P., Ponikowski, Piotr, Voors, Adriaan A., Zannad, ...

Date : 14/07/2016 Item size : 387225 bytes